Latest stories on NEON
NeOnc’s $629K Insider Buying Spree Follows Breakthrough Data and Now All Eyes Turn to the FDA
GlobeNewswire73 · bullishproduct/pr
NeOnc’s $629K Insider Buying Spree Follows Breakthrough Data and Now All Eyes Turn to the FDA
StockTitan73 · bullishproduct/pr
Investor Determination to Beat Cancer Puts NeOnc’s Novel Therapies and Patented Platform in Focus
StockTitan63 · neutralproduct/pr
Insiders Continue Buying, as NeOnc Moves NEO100 Toward Its Next Regulatory Test
StockTitan58 · neutralproduct/pr
NeOnc Technologies prices 3.57M shares at $4.20 in registered direct offering
The Fly28 · bearishgeneral
NeOnc’s Clinical Story Is Now the Main Event
StockTitan63 · neutralproduct/pr
NeOnc Technologies- Talk Is Cheap, Insider Buying Isn’t
StockTitan63 · neutralgeneral
Neonode reports Q2 EPS (13c) vs. (12c) last year
The Fly51 · neutralearnings
Why is Neonode stock sliding today?
Investing.com Markets50 · neutralgeneral
Neonode reports Q2 results
Seeking Alpha34 · bearishearnings
NeOnc Technologies shares jump after positive Phase 2a glioma results
InvestorsHub73 · bullishproduct/pr
Neonode Reports Quarter Ended June 30, 2026 Financial Results
PR Newswire50 · neutralearnings
Neonode Inc. (NEON) files 8-K
SEC 8-K50 · neutralgeneral
NeOnc Technologies Says Brain Tumor Drug Trial Met Primary Endpoint
MarketWatch73 · bullishproduct/pr
NeOnc Technologies stock jumps on positive glioma trial data
Investing.com Markets73 · bullishproduct/pr
NeOnc Technologies Reports Positive Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma
StockTitan73 · bullishproduct/pr
Neonode Inc. (NEON) files 8-K
SEC 8-K34 · bearishgeneral
Neonode Shareholders Reaffirm Board, Auditor and Executive Pay
TipRanks50 · neutralgeneral
Neonode Inc. (NEON) files 8-K
SEC 8-K50 · neutralgeneral
Neonode Reports Quarter Ended March 31, 2026 Financial Results
PR Newswire50 · neutralearnings